FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213794002> ?p ?o ?g. }

• W3213794002 endingPage "166" @default.
• W3213794002 startingPage "143" @default.
• W3213794002 abstract "Aims: Hypoxic-ischaemic encephalopathy (HIE) is one of the most serious complications in neonates and infants. Mesenchymal stromal cell (MSC)-based therapy is emerging as a promising treatment avenue for HIE. However, despite its enormous potential, the clinical application of MSCs is limited by cell heterogeneity, low isolation efficiency and unpredictable effectiveness. In this study, we examined the therapeutic effects and underlying mechanisms of human pluripotent stem cell-derived ectomesenchymal stromal cells (hPSC-EMSCs) in a rat model of HIE. Methods: hPSC-EMSCs were induced from either human embryonic stem cells or induced pluripotent stem cells. Stem cells or the conditioned medium (CM) derived from stem cells were delivered intracranially or intranasally to neonatal rats with HIE. Human umbilical cord-derived MSCs (hUC-MSCs) were used as the therapeutic comparison control and phosphate-buffered saline (PBS) was used as a negative control. Lesion size, apoptosis, neurogenesis, astrogliosis and microgliosis were evaluated. The rotarod test and Morris water maze were used to determine brain functional recovery. The PC-12 cell line, rat primary cortical neurons and neural progenitor cells were used to evaluate neurite outgrowth and the neuroprotective and neurogenesis effects of hPSC-EMSCs/hUC-MSCs. RNA-seq and enzyme-linked immunosorbent assays were used to determine the secretory factors that were differentially expressed between hPSC-EMSCs and hUC-MSCs. The activation and suppression of extracellular signal-regulated kinase (ERK) and cAMP response element-binding protein (CREB) were characterised using western blotting and immunofluorescent staining. Results: hPSC-EMSCs showed a higher neuroprotective potential than hUC-MSCs, as demonstrated by a more significant reduction in lesion size and apoptosis in the rat brain following hypoxia-ischaemia (HI). Compared with PBS treatment, hPSC-EMSCs promoted endogenous neurogenesis and alleviated astrogliosis and microgliosis. hPSC-EMSCs were more effective than hUC-MSCs. hPSC-EMSCs achieved a greater recovery of brain function than hUC-MSCs and PBS in rats with HIE. CM derived from hPSC-EMSCs had neuroprotective and neurorestorative effects in vitro through anti-apoptotic and neurite outgrowth- and neurogenesis-promoting effects. Direct comparisons between hPSC-EMSCs and hUC-MSCs revealed the significant enrichment of a group of secretory factors in hPSC-EMSCs, including nerve growth factor (NGF), platelet-derived growth factor-AA and transforming growth factor-β2, which are involved in neurogenesis, synaptic transmission and neurotransmitter transport, respectively. Mechanistically, the CM derived from hPSC-EMSCs was found to potentiate NGF-induced neurite outgrowth and the neuronal differentiation of NPCs via the ERK/CREB pathway. Suppression of ERK or CREB abolished CM-potentiated neuritogenesis and neuronal differentiation. Finally, intranasal delivery of the CM derived from hPSC-EMSCs significantly reduced brain lesion size, promoted endogenous neurogenesis, mitigated inflammatory responses and improved functional recovery in rats with HIE. Conclusion: hPSC-EMSCs promote functional recovery after HI through multifaceted neuromodulatory activities via paracrine/trophic mechanisms. We propose the use of hPSC-EMSCs for the treatment of HIE, as they offer an excellent unlimited cellular source of MSCs." @default.
• W3213794002 created "2021-11-22" @default.
• W3213794002 creator A5000984081 @default.
• W3213794002 creator A5006537767 @default.
• W3213794002 creator A5044244957 @default.
• W3213794002 creator A5048153239 @default.
• W3213794002 creator A5053932191 @default.
• W3213794002 creator A5056582943 @default.
• W3213794002 creator A5060931265 @default.
• W3213794002 creator A5066848173 @default.
• W3213794002 creator A5074942308 @default.
• W3213794002 creator A5086372378 @default.
• W3213794002 creator A5089756389 @default.
• W3213794002 creator A5091049728 @default.
• W3213794002 date "2022-01-01" @default.
• W3213794002 modified "2023-10-01" @default.
• W3213794002 title "Human pluripotent stem cell-derived ectomesenchymal stromal cells promote more robust functional recovery than umbilical cord-derived mesenchymal stromal cells after hypoxic-ischaemic brain damage" @default.
• W3213794002 cites W1503617838 @default.
• W3213794002 cites W1592983944 @default.
• W3213794002 cites W1967112356 @default.
• W3213794002 cites W1974212976 @default.
• W3213794002 cites W1983920067 @default.
• W3213794002 cites W1995819749 @default.
• W3213794002 cites W2004639056 @default.
• W3213794002 cites W2019529018 @default.
• W3213794002 cites W2020274583 @default.
• W3213794002 cites W2023154712 @default.
• W3213794002 cites W2023628945 @default.
• W3213794002 cites W2034188706 @default.
• W3213794002 cites W2039533211 @default.
• W3213794002 cites W2046411097 @default.
• W3213794002 cites W2047628664 @default.
• W3213794002 cites W2052750818 @default.
• W3213794002 cites W2059499601 @default.
• W3213794002 cites W2067591094 @default.
• W3213794002 cites W2069735923 @default.
• W3213794002 cites W2071141381 @default.
• W3213794002 cites W2082030284 @default.
• W3213794002 cites W2085233862 @default.
• W3213794002 cites W2098176076 @default.
• W3213794002 cites W2122008309 @default.
• W3213794002 cites W2122275460 @default.
• W3213794002 cites W2123296223 @default.
• W3213794002 cites W2129298171 @default.
• W3213794002 cites W2131916287 @default.
• W3213794002 cites W2133112122 @default.
• W3213794002 cites W2136967026 @default.
• W3213794002 cites W2146516445 @default.
• W3213794002 cites W2155228504 @default.
• W3213794002 cites W2164127547 @default.
• W3213794002 cites W2164974142 @default.
• W3213794002 cites W2169473035 @default.
• W3213794002 cites W2170470411 @default.
• W3213794002 cites W2283292644 @default.
• W3213794002 cites W2344792891 @default.
• W3213794002 cites W2460301135 @default.
• W3213794002 cites W2511109053 @default.
• W3213794002 cites W2513683484 @default.
• W3213794002 cites W2613986718 @default.
• W3213794002 cites W2775540708 @default.
• W3213794002 cites W2789429822 @default.
• W3213794002 cites W2796599499 @default.
• W3213794002 cites W2803932714 @default.
• W3213794002 cites W2887097990 @default.
• W3213794002 cites W2909822858 @default.
• W3213794002 cites W2928665623 @default.
• W3213794002 cites W2939740384 @default.
• W3213794002 cites W2943388335 @default.
• W3213794002 cites W2943803640 @default.
• W3213794002 cites W2945281383 @default.
• W3213794002 cites W2971714255 @default.
• W3213794002 cites W2973745687 @default.
• W3213794002 cites W2978483689 @default.
• W3213794002 cites W2981557599 @default.
• W3213794002 cites W2982149985 @default.
• W3213794002 cites W2995210453 @default.
• W3213794002 cites W3006800528 @default.
• W3213794002 cites W3007972554 @default.
• W3213794002 cites W3011296169 @default.
• W3213794002 cites W3011567146 @default.
• W3213794002 cites W3016600470 @default.
• W3213794002 cites W3044820393 @default.
• W3213794002 cites W3045011626 @default.
• W3213794002 cites W3108025081 @default.
• W3213794002 cites W3111127843 @default.
• W3213794002 cites W3116350437 @default.
• W3213794002 cites W3118680511 @default.
• W3213794002 cites W3120365186 @default.
• W3213794002 cites W3141143136 @default.
• W3213794002 cites W3141266520 @default.
• W3213794002 cites W3162558162 @default.
• W3213794002 cites W3173681327 @default.
• W3213794002 cites W3180590157 @default.
• W3213794002 doi "https://doi.org/10.7150/thno.57234" @default.
• W3213794002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34987639" @default.
• W3213794002 hasPublicationYear "2022" @default.
• W3213794002 type Work @default.
• W3213794002 sameAs 3213794002 @default.

• next